{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:47:38Z","timestamp":1759798058988,"version":"build-2065373602"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10517-025-06495-8","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:12:29Z","timestamp":1758733949000},"page":"388-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in Lipid Metabolism under Alloxan Diabetes in Laboratory Animals and the Influence of Antidiabetic and Hypoglycemic Therapy on These Changes"],"prefix":"10.1007","volume":"179","author":[{"given":"I. V.","family":"Ralchenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chilali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Shalabodov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"6495_CR1","unstructured":"Berestneva SV, Uryasev OM, Solovieva AV. Type 2 diabetes: a modern view of the problem. Zemskij Vra\u010d. 2019;(1):5-12. Russian."},{"key":"6495_CR2","unstructured":"Chernova AL, Katsay AE, Fominykh AA. Diabetes mellitus type 1: etiology, pathogenesis, clinic, treatment. Zametki U\u010d\u00ebnogo. 2021;(8):164-7. Russian."},{"issue":"3","key":"6495_CR3","first-page":"45","volume":"11","author":"OO Oguntibeju","year":"2019","unstructured":"Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45-63.","journal-title":"Int J Physiol Pathophysiol Pharmacol."},{"key":"6495_CR4","doi-asserted-by":"publisher","first-page":"8427034","DOI":"10.1155\/2017\/8427034","volume":"2017","author":"K Bensiameur-Touati","year":"2017","unstructured":"Bensiameur-Touati K, Kacimi G, Haffaf EM, et al. In vivo subacute toxicity and antidiabetic effect of aqueous extract of Nigella sativa. Evid Based Complement Alternat Med. 2017;2017:8427034. https:\/\/doi.org\/10.1155\/2017\/8427034","journal-title":"Evid Based Complement Alternat Med."},{"key":"6495_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.20333\/25000136-2023-3-78-83","volume":"3","author":"IV Ralchenko","year":"2023","unstructured":"Ralchenko IV, Shilali S, Tolstoquzov SN. The effect of metformin and insulin on metabolic disorders in alloxan diabetes. Siberian Med Rev. 2023;(3):78-83. https:\/\/doi.org\/10.20333\/25000136-2023-3-78-83","journal-title":"Siberian Med Rev."},{"key":"6495_CR6","doi-asserted-by":"publisher","unstructured":"Batishcheva GA, Bibik EYu, Ketova ES. Experimental models of diabetes mellitus (literary review). Nau\u010dno-Medicinskij Vestnik Central'nogo \u010cernozem'\u00e2. 2022;(90):25-31. Russian. https:\/\/doi.org\/10.18499\/1990-472X-2022-0-90-25-31","DOI":"10.18499\/1990-472X-2022-0-90-25-31"},{"key":"6495_CR7","unstructured":"Bafaev JT, Mavlanov AA, Xamidova ZN. Features of the typological properties of animals in the clinical course of an experimental model of alloxan diabetes. New Day in Medicine. 2022;(1):257-63. Russian."},{"key":"6495_CR8","doi-asserted-by":"publisher","first-page":"7489795","DOI":"10.1155\/2020\/7489795","volume":"2020","author":"E Papachristoforou","year":"2020","unstructured":"Papachristoforou E, Lambadiari V, Maratou E, et al. Association of Glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res. 2020;2020:7489795. https:\/\/doi.org\/10.1155\/2020\/7489795","journal-title":"J Diabetes Res."},{"key":"6495_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.878585","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen H, Li H, et al. Effect and safety of adding metformin to insulin therapy in treating adolescents with type 1 diabetes mellitus: an updated meta-analysis of 10 randomized controlled trials. Front Endocrinol (Lausanne). 2022;13:878585. https:\/\/doi.org\/10.3389\/fendo.2022.878585","journal-title":"Front Endocrinol (Lausanne)."},{"key":"6495_CR10","doi-asserted-by":"crossref","unstructured":"Telushkin PK, Potapov PP, Medvedeva NB. Insulin hypoglycemia and gluconeogenesis activation in the liver of rats with diabetes. Modern Problems of Science and Education. 2022;(1). URL: https:\/\/science-education.ru\/ru\/article\/view?id=31510","DOI":"10.17513\/spno.31510"},{"issue":"1","key":"6495_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S1957-2557(09)70104-X","volume":"3","author":"M Foretz","year":"2009","unstructured":"Foretz M, Viollet B. Hepatic mechanism of metformin action in type 2 diabetes mellitus. M\u00e9decine des Maladies M\u00e9taboliques. 2009;3(1):48-54. https:\/\/doi.org\/10.1016\/S1957-2557(09)70104-X","journal-title":"M\u00e9decine des Maladies M\u00e9taboliques."},{"key":"6495_CR12","unstructured":"Shishkova VN. Current state of the issue of metformin therapy of diabetes mellitus: a combination of benefit and risk. Consilium Medicum. 2010;12(5):130-4. Russian."},{"issue":"2","key":"6495_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/dom.13869","volume":"22","author":"DJ Sansome","year":"2020","unstructured":"Sansome DJ, Xie C, Veedfald S, et al. Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids. Diabetes Obes Metab. 2020;22(2):141-8. https:\/\/doi.org\/10.1111\/dom.13869","journal-title":"Diabetes Obes Metab."},{"key":"6495_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.625701","volume":"12","author":"D Stefanovski","year":"2021","unstructured":"Stefanovski D, Punjabi NM, Boston RC, et al. Insulin action, glucose homeostasis and free fatty acid metabolism: insights from a novel model. Front Endocrinol (Lausanne). 2021;12:625701. https:\/\/doi.org\/10.3389\/fendo.2021.625701","journal-title":"Front Endocrinol (Lausanne)."},{"key":"6495_CR15","doi-asserted-by":"publisher","unstructured":"Mkrtumyan AM, Markova TN, Ovchinnikova MA. Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action. Diabetes Mellitus. 2023;26(6):585-95. Russian. https:\/\/doi.org\/10.14341\/DM13044","DOI":"10.14341\/DM13044"},{"key":"6495_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","volume":"10","author":"G Vial","year":"2019","unstructured":"Vial G, Detaille D, Guigas B. Role of mitochondria in the mechanism(s) of action of metformin. Front Endocrinol (Lausanne). 2019;10:294. https:\/\/doi.org\/10.3389\/fendo.2019.00294","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"6495_CR17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.dsx.2020.07.036","volume":"14","author":"KA Adeshara","year":"2020","unstructured":"Adeshara KA, Bangar NS, Doshi PR, et al. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study. Diabetes Metab Syndr. 2020;14(5):1449-58. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.036","journal-title":"Diabetes Metab Syndr."},{"key":"6495_CR18","doi-asserted-by":"publisher","unstructured":"Gruzdeva OV, Bychkova EE, Dyleva JA. Cardiovascular effects of metformin: focus on adipose tissue metabolism. Ateroskleroz. 2022;18(3):236-46. Russian. https:\/\/doi.org\/10.52727\/2078-256X-2022-18-3-236-246","DOI":"10.52727\/2078-256X-2022-18-3-236-246"}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-025-06495-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:14:45Z","timestamp":1759763685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-025-06495-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6495"],"URL":"https:\/\/doi.org\/10.1007\/s10517-025-06495-8","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"type":"print","value":"0007-4888"},{"type":"electronic","value":"1573-8221"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}